Levin Capital Strategies, L.P. Standard Biotools Inc. Transaction History

Levin Capital Strategies, L.P.

$1.03 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$3.94 - $7.09 $113,026 - $203,390	-28,687 Reduced 67.72%	13,672 $62,000
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $89,287 - $141,712	-16,383 Reduced 27.89%	42,359 $254,000
Q3 2020 Nov 17, 2020	SELL	$4.34 - $11.43 $567,342 - $1.49 Million	-130,724 Reduced 69.0%	58,742 $436,000
Q2 2020 Aug 13, 2020	BUY	$1.85 - $5.29 $49,724 - $142,184	26,878 Added 16.53%	189,466 $760,000
Q1 2020 May 13, 2020	BUY	$1.24 - $4.35 $26,040 - $91,349	21,000 Added 14.83%	162,588 $413,000
Q4 2019 Feb 10, 2020	SELL	$2.3 - $5.12 $27,234 - $60,625	-11,841 Reduced 7.72%	141,588 $493,000
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $97,230 - $255,150	-21,000 Reduced 12.04%	153,429 $710,000
Q2 2019 Aug 13, 2019	SELL	$11.49 - $14.17 $73,846 - $91,070	-6,427 Reduced 3.55%	174,429 $2.15 Million
Q1 2019 May 13, 2019	SELL	$8.47 - $14.36 $79.5 Million - $135 Million	-9,386,212 Reduced 98.11%	180,856 $2.4 Million
Q4 2018 Feb 05, 2019	SELL	$7.18 - $8.83 $4.56 Million - $5.6 Million	-634,723 Reduced 6.22%	9,567,068 $82.5 Million
Q3 2018 Oct 29, 2018	SELL	$5.92 - $8.35 $38,663 - $54,533	-6,531 Reduced 0.06%	10,201,791 $76.4 Million
Q2 2018 Aug 07, 2018	BUY	$4.86 - $6.24 $2.4 Million - $3.08 Million	492,914 Added 5.07%	10,208,322 $60.8 Million
Q1 2018 May 18, 2018	BUY	$5.75 - $7.97 $3.15 Million - $4.37 Million	548,338 Added 5.98%	9,715,408 $56.7 Million
Q4 2017 Feb 09, 2018	BUY	$4.46 - $6.45 $2.07 Million - $2.99 Million	463,310 Added 5.32%	9,167,070 $54 Million
Q3 2017 Nov 13, 2017	BUY	$3.55 - $5.49 $30.9 Million - $47.8 Million	8,703,760	8,703,760 $43.9 Million

Others Institutions Holding LAB

# of Institutions

142

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $128M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account